Molecules and Cells

, Volume 27, Issue 1, pp 15–19 | Cite as

Regulation of Notch1/NICD and Hes1 expressions by GSK-3α/β

  • Yun Hye Jin
  • Hangun Kim
  • Minsoo Oh
  • Hyunkyung Ki
  • Kwonseop KimEmail author


Notch signaling is controlled at multiple levels. In particular, stabilized Notch receptor activation directly affects the transcriptional activations of Notch target genes. Although some progress has been made in terms of defining the regulatory mechanism that alters Notch stability, it has not been determined whether Notch1/NICD stability is regulated by GSK-3α. Here, we show that Notch1/NICD levels are significantly regulated by GSK-3β and by GSK-3α. Treatment with LiCl (a specific GSK-3 inhibitor) or the overexpression of the kinase-inactive forms of GSK-3α/β significantly increased Notch1/NICD levels. Endogenous NICD levels were also increased by either GSK-3α/β- or GSK-3α-specific siRNA. Furthermore, it was found that GSK-3α binds to Notch1. Deletion analysis showed that at least three Thr residues in Notch1 (Thr-1851, 2123, and 2125) are critical for its response to LiCl, which increased not only the transcriptional activity of endogenous NICD but also Hes1 mRNA levels. Taken together, our results indicate that GSK-3α is a negative regulator of Notch1/NICD.


GSK-3 Hes1 LiCl NICD Notch1 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Asuni, A.A., Hooper, C., Reynolds, C.H., Lovestone, S., Anderton, B.H., and Killick, R. (2006). GSK-3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt. Eur. J. Neurosci. 24, 3387–3392.CrossRefPubMedGoogle Scholar
  2. Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R.A., and Israel, A. (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207–216.CrossRefPubMedGoogle Scholar
  3. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785–789.CrossRefPubMedGoogle Scholar
  4. Doble, B.W., Patel, S., Wood, G.A., Kockeritz, L.K., and Woodgett, J.R. (2007). Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957–971.CrossRefPubMedGoogle Scholar
  5. Espinosa, L., Ingles-Esteve, J., Aguilera, C., and Bigas, A. (2003). Phosphorylation by glycogen synthase kinase-3 beta downregulates Notch activity, a link for Notch and Wnt pathways. J. Biol. Chem. 278, 32227–32235.CrossRefPubMedGoogle Scholar
  6. Foltz, D.R., Santiago, M.C., Berechid, B.E., and Nye, J.S. (2002). Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr. Biol. 12, 1006–1011.CrossRefPubMedGoogle Scholar
  7. Goto, H., Kawano, K., Kobayashi, I., Sakai, H., and Yanagisawa, S. (2002). Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol. 38, 549–556.CrossRefPubMedGoogle Scholar
  8. Grimes, C.A., and Jope, R.S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391–426.CrossRefPubMedGoogle Scholar
  9. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., and Woodgett, J.R. (2000). Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86–90.CrossRefPubMedGoogle Scholar
  10. Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F., and Woodgett, J.R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803–808.PubMedGoogle Scholar
  11. Iso, T., Kedes, L., and Hamamori, Y. (2003). HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194, 237–255.CrossRefPubMedGoogle Scholar
  12. Kim, H., Ki, H., Park, H.S., and Kim, K. (2005). Presenilin-1 D257A and D385A mutants fail to cleave Notch in their endoproteolyzed forms, but only presenilin-1 D385A mutant can restore its gamma-secretase activity with the compensatory overexpression of normal C-terminal fragment. J. Biol. Chem. 280, 22462–22472.CrossRefPubMedGoogle Scholar
  13. Koivisto, L., Jiang, G., Hakkinen, L., Chan, B., and Larjava, H. (2006). HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha. Exp. Cell Res. 312, 2791–2805.CrossRefPubMedGoogle Scholar
  14. Kopan, R. (2002). Notch: a membrane-bound transcription factor. J. Cell Sci. 115, 1095–1097.PubMedGoogle Scholar
  15. Lau, K.F., Miller, C.C., Anderton, B.H., and Shaw, P.C. (1999). Expression analysis of glycogen synthase kinase-3 in human tissues. J. Pept. Res. 54, 85–91.CrossRefPubMedGoogle Scholar
  16. Lee, H.C., Tsai, J.N., Liao, P.Y., Tsai, W.Y., Lin, K.Y., Chuang, C.C., Sun, C.K., Chang, W.C., and Tsai, H.J. (2007). Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo. BMC Dev. Biol. 7, 93.CrossRefPubMedGoogle Scholar
  17. Liao, X., Thrasher, J.B., Holzbeierlein, J., Stanley, S., and Li, B. (2004). Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 145, 2941–2949.CrossRefPubMedGoogle Scholar
  18. Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seidah, N.G., and Israel, A. (1998). The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95, 8108–8112.CrossRefPubMedGoogle Scholar
  19. Phiel, C.J., Wilson, C.A., Lee, V.M., and Klein, P.S. (2003). GSK-3alpha regulates production of Alzheimer’s disease amyloidbeta peptides. Nature 423, 435–439.CrossRefPubMedGoogle Scholar
  20. Shaw, P.C., Davies, A.F., Lau, K.F., Garcia-Barcelo, M., Waye, M.M., Lovestone, S., Miller, C.C., and Anderton, B.H. (1998). Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 41, 720–727.CrossRefPubMedGoogle Scholar
  21. Wang, Q.M., Fiol, C.J., DePaoli-Roach, A.A., and Roach, P.J. (1994). Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14566–14574.PubMedGoogle Scholar
  22. Woodgett, J.R. (1990). Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431–2438.PubMedGoogle Scholar
  23. Yao, H.B., Shaw, P.C., Wong, C.C., and Wan, D.C. (2002). Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J. Chem. Neuroanat. 23, 291–297.CrossRefPubMedGoogle Scholar

Copyright information

© The Korean Society for Molecular and Cellular Biology and Springer Netherlands 2009

Authors and Affiliations

  • Yun Hye Jin
    • 1
  • Hangun Kim
    • 1
  • Minsoo Oh
    • 1
  • Hyunkyung Ki
    • 1
  • Kwonseop Kim
    • 1
    Email author
  1. 1.College of Pharmacy and Research Institute of Drug DevelopmentChonnam National UniversityGwangjuKorea

Personalised recommendations